InvestorsHub Logo
icon url

1776club

04/14/22 12:44 PM

#13476 RE: dia76ca #13474

Can't time the market but the trend is not your friend. The clarion call of "it's cheap, buy" has followed this down. tremendous potential here but in all honesty should have sold it last year but you never know in a pandemic with a pharmaceutical when a EUA would be given, and fortune reversed. I'm looking at my trend line and the stock is following it. If the company does not have real income >$100mm from COVI-STIX in the 1st Quarter filing this could hit $1.50 or lower by June, all of which would not be due to the company alone but to market forces as well.
icon url

RMacchio

04/14/22 4:46 PM

#13481 RE: dia76ca #13474

COVISHIELD will be needed!


Unfortunately, COVISHIELD is superior to the Merck and Pfizer therapies but, without a big pharma behind it, it will not get approved. It's like the old joke during the IBM mainframe days... What's the difference between an IBM computer and a computer from Digital/Honeywell/ControlData/etc. Answer: Nothing, but you can sell an IBM computer. The FDA appears to be owned by big Pharma... why else would a failed Ebola castoff like Remdesivir ever get approved for treating COVID?
icon url

Brandywhitneylady

04/14/22 8:16 PM

#13482 RE: dia76ca #13474

3 should, 1 could, a potential and an expect.......sounds like the Dr.
icon url

1776club

04/14/22 8:29 PM

#13485 RE: dia76ca #13474

Hey, while we are on the subject of happenings what do you think is going on with the CBD plantation and Sorrento's solubility of CBD in water formulation. It has been three years and not a peep.